Biotic Resources, Volume. 47, Issue 3, 242(2025)

Research progress on health claims of Chaenomeles speciosa

Yuebin Ge, Zhangyaoyu Yuan, Mingzhen Zhang, Songtong Wan, Hang Sun, Li Xiang, and Shenghu Chen*
Author Affiliations
  • School of Pharmaceutical Sciences,South-Central Minzu University,Wuhan430074,, China
  • show less

    Chaenomeles speciosa is the fruit of Chaenomeles speciosa (Sweet) Nakai, a perennial deciduous woody plant belonging to the Rosaceae family, serves as a dual-purpose resource for both medicine and food, demonstrating significant value in pharmaceutical, dietary, and nutraceutical applications. This review systematically summarizes recent advances in bioactive constituents of C. speciosa, including terpenoids, organic acids, and flavonoids, along with their phys?iological activities such as anti-inflammatory, anti-rheumatic, and uric acid-lowering effects. Furthermore, health claims and safety profiles are critically evaluated. Through systematic literature review and analysis, we propose evidence-based health claims for C. speciosa: aiding in lowering uric acid levels and regulating immune function, thereby providing scientific references for its medicinal and dietary applications. This paper is expected to facilitate the development and utilization of C. speciosa-derived products in functional foods and therapeutic interventions.

    Tools

    Get Citation

    Copy Citation Text

    Yuebin Ge, Zhangyaoyu Yuan, Mingzhen Zhang, Songtong Wan, Hang Sun, Li Xiang, Shenghu Chen. Research progress on health claims of Chaenomeles speciosa[J]. Biotic Resources, 2025, 47(3): 242

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Dec. 16, 2024

    Accepted: Jun. 9, 2025

    Published Online: Jul. 28, 2025

    The Author Email: Shenghu Chen (283547652@qq.com)

    DOI:10.14188/j.ajsh.20241216001

    Topics